HK2, which catalyzes glucose to glucose 6-phosphate (G6P) in the glycolytic pathway, is negatively related to poor prognosis in patients with HCC and is also mediated by HIF-1a (Agnihotri and Zadeh, 2016; DeWaal et al., 2018). The gene discussed is HIF1A; the disease is hepatocellular carcinoma.